2023 Q1 Form 10-K Financial Statement

#000121390023022430 Filed on March 23, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $7.671M $16.85M $84.39M
YoY Change -60.51% -14.26% 92.39%
Cost Of Revenue $4.678M $6.760M $47.71M
YoY Change -44.39% 83.39% 381.76%
Gross Profit $2.993M $10.09M $36.67M
YoY Change -72.82% -36.8% 7.99%
Gross Profit Margin 39.01% 59.89% 43.46%
Selling, General & Admin $4.977M $5.856M $25.85M
YoY Change -27.52% 7.69% -32.95%
% of Gross Profit 166.32% 58.02% 70.49%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $7.963M $17.14M $63.20M
YoY Change -42.32% 179.31% 347.79%
% of Gross Profit 266.07% 169.82% 172.35%
Operating Expenses $14.69M $22.99M $92.06M
YoY Change -28.94% 98.68% 74.81%
Operating Profit -$11.70M -$12.90M -$44.09M
YoY Change 21.1% -393.54% 135.69%
Interest Expense $835.1K -$15.05M $6.064M
YoY Change -143.14% 849.54% -305.9%
% of Operating Profit
Other Income/Expense, Net $864.0K $469.6K $2.402M
YoY Change 3433.64% 17.41% 166.06%
Pretax Income -$10.83M -$18.81M -$54.04M
YoY Change -6.37% -786.5% 19.59%
Income Tax $548.1K $0.00
% Of Pretax Income
Net Earnings -$11.10M -$18.45M -$52.76M
YoY Change -2.06% -902.14% 17.34%
Net Earnings / Revenue -144.73% -109.46% -62.53%
Basic Earnings Per Share -$0.80 -$4.16
Diluted Earnings Per Share -$0.80 -$1.36 -$0.61
COMMON SHARES
Basic Shares Outstanding 14.13M shares 81.57M shares 12.70M shares
Diluted Shares Outstanding 13.95M shares 12.70M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.387M $4.190M $946.3K
YoY Change -76.1% -23.36% -82.69%
Cash & Equivalents $1.387M $946.3K $946.3K
Short-Term Investments $3.244M
Other Short-Term Assets $7.406M $8.935M $8.935M
YoY Change 275.93% 2295.74% 2295.74%
Inventory
Prepaid Expenses $1.931M $3.489M
Receivables $7.950M $10.46M $10.46M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $16.74M $20.34M $20.34M
YoY Change 30.61% 77.68% 77.68%
LONG-TERM ASSETS
Property, Plant & Equipment $84.56M $91.02M $93.84M
YoY Change -43.24% 18.3% -29.06%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $12.63M $16.63M $16.63M
YoY Change 3650.18% 4988.53% 4988.53%
Other Assets $224.1K $2.524M $2.524M
YoY Change -94.16% 102.53%
Total Long-Term Assets $99.99M $113.0M $113.0M
YoY Change -34.71% -15.58% -15.58%
TOTAL ASSETS
Total Short-Term Assets $16.74M $20.34M $20.34M
Total Long-Term Assets $99.99M $113.0M $113.0M
Total Assets $116.7M $133.3M $133.3M
YoY Change -29.67% -8.24% -8.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $24.18M $10.57M $10.57M
YoY Change 72.76% 36.47% 121.23%
Accrued Expenses $1.398M $166.7K $1.300M
YoY Change -0.88% -86.37% -65.49%
Deferred Revenue
YoY Change
Short-Term Debt $22.94M $23.61M $23.61M
YoY Change 43.07% 112.8% 112.8%
Long-Term Debt Due $31.28K $30.70K $30.70K
YoY Change 8.01% 278.55% 278.55%
Total Short-Term Liabilities $48.55M $35.51M $35.51M
YoY Change 54.27% 76.92% 76.92%
LONG-TERM LIABILITIES
Long-Term Debt $75.19K $4510B $4.593M
YoY Change -99.72% 58736550.45% -40.18%
Other Long-Term Liabilities $1.371M $17.06M $17.06M
YoY Change -61.06% 475.69% 475.69%
Total Long-Term Liabilities $1.446M $4510B $21.65M
YoY Change -95.27% 42382417.32% 103.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $48.55M $35.51M $35.51M
Total Long-Term Liabilities $1.446M $4510B $21.65M
Total Liabilities $50.00M $57.16M $56.26M
YoY Change -18.89% 86.11% 84.15%
SHAREHOLDERS EQUITY
Retained Earnings -$133.4M -$122.3M
YoY Change 71.9%
Common Stock $14.13K $13.63K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $67.88M $77.07M $77.07M
YoY Change
Total Liabilities & Shareholders Equity $116.7M $133.3M $133.3M
YoY Change -29.67% -8.24% -8.24%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$11.10M -$18.45M -$52.76M
YoY Change -2.06% -902.14% 17.34%
Depreciation, Depletion And Amortization $7.963M $17.14M $63.20M
YoY Change -42.32% 179.31% 347.79%
Cash From Operating Activities $1.317M -$10.88M $14.26M
YoY Change -77.55% -174.47% -37.89%
INVESTING ACTIVITIES
Capital Expenditures $3.149M $12.86M $49.98M
YoY Change -110.62% -120.07% -138.99%
Acquisitions
YoY Change
Other Investing Activities $7.218M $35.79M $49.49M
YoY Change -1987.35% -67280.64%
Cash From Investing Activities $4.069M $22.93M -$32.54M
YoY Change -113.72% -134.74% -74.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $5.398M $28.00M
YoY Change
Cash From Financing Activities -$4.936M -12.25M $13.99M
YoY Change -121.02% -151.43% -87.27%
NET CHANGE
Cash From Operating Activities $1.317M -10.88M $14.26M
Cash From Investing Activities $4.069M 22.93M -$32.54M
Cash From Financing Activities -$4.936M -12.25M $13.99M
Net Change In Cash $441.1K -212.6K -$4.521M
YoY Change -242.04% -99.23% -199.13%
FREE CASH FLOW
Cash From Operating Activities $1.317M -$10.88M $14.26M
Capital Expenditures $3.149M $12.86M $49.98M
Free Cash Flow -$1.832M -$23.75M -$35.72M
YoY Change -105.16% -130.17% -123.64%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 migi Net Energy Benefits
NetEnergyBenefits
usd
CY2022 migi Lo2 A Write Off
LO2AWriteOff
usd
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
usd
CY2022 dei Entity File Number
EntityFileNumber
001-40849
CY2022 dei Entity Registrant Name
EntityRegistrantName
Mawson Infrastructure Group, Inc.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
88-0445167
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
201 Clark Street
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Sharon
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
16146
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2022 dei City Area Code
CityAreaCode
+61 2
CY2022 dei Local Phone Number
LocalPhoneNumber
8624 6130
CY2022 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2022 dei Trading Symbol
TradingSymbol
MIGI
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
62350000 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14131110 shares
CY2022 dei Auditor Firm
AuditorFirmId
6714
CY2022 dei Auditor Name
AuditorName
Anthony Rose
CY2022 dei Auditor Location
AuditorLocation
Sydney, NSW, Australia
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
946265 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5467273 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3488868 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
332154 usd
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
10458076 usd
CY2021Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
5606780 usd
CY2022Q4 migi Assets Held For Sales
AssetsHeldForSales
5446059 usd
CY2021Q4 migi Cryptocurrencies
Cryptocurrencies
40800 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
20339268 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
11447007 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
91016498 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
76936850 usd
CY2022Q4 us-gaap Derivative Assets Noncurrent
DerivativeAssetsNoncurrent
11299971 usd
CY2021Q4 migi Equipment Deposits
EquipmentDeposits
51369216 usd
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
2085373 usd
CY2022Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
3243957 usd
CY2021Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
326801 usd
CY2022Q4 migi Security Deposits
SecurityDeposits
2524065 usd
CY2021Q4 migi Security Deposits
SecurityDeposits
1246236 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2819933 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3968262 usd
CY2022Q4 us-gaap Assets
Assets
133329065 usd
CY2021Q4 us-gaap Assets
Assets
145294372 usd
CY2022Q4 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
10572061 usd
CY2021Q4 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
7746988 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1300062 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1222382 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
30702 usd
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
8105 usd
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
23610583 usd
CY2021Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
11095388 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
35513408 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
20072863 usd
CY2022Q4 us-gaap Other Loans Payable Long Term
OtherLoansPayableLongTerm
15328445 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1727975 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2962765 usd
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
83223 usd
CY2021Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
38764 usd
CY2022Q4 migi Longterm Borrowings
LongtermBorrowings
4509894 usd
CY2021Q4 migi Longterm Borrowings
LongtermBorrowings
7639391 usd
CY2022Q4 us-gaap Liabilities
Liabilities
57162945 usd
CY2021Q4 us-gaap Liabilities
Liabilities
30713783 usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13625882 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13625882 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13625882 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13625882 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 migi Common Stock Value1
CommonStockValue1
194308185 usd
CY2021Q4 migi Common Stock Value1
CommonStockValue1
186389568 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5021467 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-521094 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-122257628 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-71123259 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
77072024 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
114745215 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
-905904 usd
CY2021Q4 us-gaap Minority Interest
MinorityInterest
-164626 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
133329065 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
145294372 usd
CY2022 migi Cryptocurrency Mining Revenue
CryptocurrencyMiningRevenue
-43106162 usd
CY2021 migi Cryptocurrency Mining Revenue
CryptocurrencyMiningRevenue
-38446438 usd
CY2022 migi Hosting Co Location Revenue
HostingCoLocationRevenue
13340143 usd
CY2021 migi Hosting Co Location Revenue
HostingCoLocationRevenue
852954 usd
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
14237860 usd
CY2021 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
2157651 usd
CY2022 migi Net Energy Benefits
NetEnergyBenefits
13701242 usd
CY2021 us-gaap Sublease Income
SubleaseIncome
2405613 usd
CY2022 us-gaap Revenues
Revenues
84385407 usd
CY2021 us-gaap Revenues
Revenues
43862656 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
47714895 usd
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
9904273 usd
CY2022 us-gaap Gross Profit
GrossProfit
36670512 usd
CY2021 us-gaap Gross Profit
GrossProfit
33958383 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
25850177 usd
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16061088 usd
CY2021 migi Lo2 A Write Off
LO2AWriteOff
23963050 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
3012480 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
22491100 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
63200178 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
14113730 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
92062835 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
76628968 usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-11299971 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-44092352 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-42670585 usd
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-6673124 usd
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-932866 usd
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1254025 usd
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-368426 usd
CY2022 us-gaap Other Income
OtherIncome
2401555 usd
CY2021 us-gaap Other Income
OtherIncome
902629 usd
CY2022 us-gaap Interest Expense
InterestExpense
6063894 usd
CY2021 us-gaap Interest Expense
InterestExpense
1643724 usd
CY2022 migi Loss On Write Off Property Plant And Equipment
LossOnWriteOffPropertyPlantAndEquipment
-1560541 usd
CY2021 migi Loss On Write Off Property Plant And Equipment
LossOnWriteOffPropertyPlantAndEquipment
-470975 usd
CY2022 migi Loss On Reclassification To Assets Held For Sale
LossOnReclassificationToAssetsHeldForSale
8276440 usd
CY2022 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-1694388 usd
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
3375230 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-54035559 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-45183947 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
277717 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-54035559 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-45461664 usd
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1273251 usd
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-497944 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-52762308 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-44963720 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.16
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.79
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12695654 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9383971 shares
CY2022 us-gaap Profit Loss
ProfitLoss
-54035559 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-45461664 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5542561 usd
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
820732 usd
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-48492998 usd
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-44640932 usd
CY2022 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1275297 usd
CY2021 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-497944 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-47217701 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-44142988 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
114580589 usd
CY2022 migi Issuance Of Common Stock Net Of Offer Costs Pipe Transaction
IssuanceOfCommonStockNetOfOfferCostsPIPETransaction
543483 usd
CY2022 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
1668333 usd
CY2022 migi Issuance And Exercising Of Rs Us And Stock Options
IssuanceAndExercisingOfRSUsAndStockOptions
746972 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5877513 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-54035559 usd
CY2022 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
5540515 usd
CY2022 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
1244274 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
76166120 usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7564879 usd
CY2021 migi Late Acceptance Of Exchange Of Common Stock Of Cosmos Capital Limited For Common Stock Of
LateAcceptanceOfExchangeOfCommonStockOfCosmosCapitalLimitedForCommonStockOf
-4924659 usd
CY2021 migi Stock Issued During Period Value Issuance Of Common Stock Net Of Offer Costs Pipe Transaction
StockIssuedDuringPeriodValueIssuanceOfCommonStockNetOfOfferCostsPIPETransaction
3000000 usd
CY2021 migi Issuance Of Mandatorily Convertible Notes By Cosmos Capital
IssuanceOfMandatorilyConvertibleNotesByCosmosCapital
20301427 usd
CY2021 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
9245546 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
74921300 usd
CY2021 migi Fair Value Of Iprd Acquired Net Of Business Combination Transaction Costs
FairValueOfIPRDAcquiredNetOfBusinessCombinationTransactionCosts
24765831 usd
CY2021 migi Fair Value Adjustment Of Lo2 A Intellectual Property Revenue Sharing Obligation
FairValueAdjustmentOfLO2AIntellectualPropertyRevenueSharingObligation
5440863 usd
CY2021 migi Issuance Of Common Stock Net Of Offer Costs Pipe Transaction
IssuanceOfCommonStockNetOfOfferCostsPIPETransaction
6144295 usd
CY2021 migi Stock Issued During Period Value Issuance Of Common Stock Settlement Of Convertible Note Interest
StockIssuedDuringPeriodValueIssuanceOfCommonStockSettlementOfConvertibleNoteInterest
860371 usd
CY2021 migi Issuance And Exercising Of Rs Us And Stock Options
IssuanceAndExercisingOfRSUsAndStockOptions
11222803 usd
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
63627 usd
CY2021 migi Exercise Of Warrants For Mawson Infrastructure Group Inc Common Stock
ExerciseOfWarrantsForMawsonInfrastructureGroupIncCommonStock
124027 usd
CY2021 migi Stock Issued During Period Value Issuance Of Stock By Subsidairy To Noncontroling Interest
StockIssuedDuringPeriodValueIssuanceOfStockBySubsidairyToNoncontrolingInterest
917684 usd
CY2021 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
392479 usd
CY2021 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
-33994 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-45461664 usd
CY2021 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
820732 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
114580589 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-54035559 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-45461664 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
63200178 usd
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14113730 usd
CY2021 migi Lo2 A Write Offs
LO2AWriteOffs
23963050 usd
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
1619627 usd
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
491782 usd
CY2022 migi Unrealized Loss On Marketable Securities
UnrealizedLossOnMarketableSecurities
-1694471 usd
CY2022 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-11299971 usd
CY2022 us-gaap Other Noncash Income
OtherNoncashIncome
1448187 usd
CY2022 migi Impairment On Equity Accounted Associate Investment
ImpairmentOnEquityAccountedAssociateInvestment
2060779 usd
CY2022 migi Proceeds Received In The Form Of Shares
ProceedsReceivedInTheFormOfShares
7033825 usd
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1560541 usd
CY2022 migi Noncontrolling Interest
NoncontrollingInterest
1244274 usd
CY2022 migi Increase Decrease Investment Income
IncreaseDecreaseInvestmentIncome
1284398 usd
CY2021 migi Increase Decrease Investment Income
IncreaseDecreaseInvestmentIncome
368426 usd
CY2021 migi Interest On Convertible Notes Satisfied By Issue Of Notes
InterestOnConvertibleNotesSatisfiedByIssueOfNotes
860399 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-30502 usd
CY2022 migi Gain Loss Foreign Exchange
GainLossForeignExchange
-1547 usd
CY2021 migi Gain Loss Foreign Exchange
GainLossForeignExchange
-1026770 usd
CY2022 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-4807 usd
CY2021 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-72623 usd
CY2022 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
3012480 usd
CY2021 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
22491100 usd
CY2022 migi Gain On Disposal Of Fixed Assets
GainOnDisposalOfFixedAssets
3526226 usd
CY2021 migi Gain On Disposal Of Fixed Assets
GainOnDisposalOfFixedAssets
283434 usd
CY2021 migi Acquisition Of Wize Pharma Inc
AcquisitionOfWizePharmaInc
5436541 usd
CY2021 migi Gain Loss Noncontrolling Interest
GainLossNoncontrollingInterest
150766 usd
CY2022 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
605480 usd
CY2021 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
4991635 usd
CY2022 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
4863945 usd
CY2021 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
847872 usd
CY2022 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
21355883 usd
CY2021 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
5864742 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14256294 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
22953792 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
49978074 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
76804866 usd
CY2022 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-165316 usd
CY2022 us-gaap Proceeds From Sale Of Other Assets Investing Activities
ProceedsFromSaleOfOtherAssetsInvestingActivities
27170531 usd
CY2021 migi Purchase Of Investment Shares
PurchaseOfInvestmentShares
767850 usd
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
22156131 usd
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
694181 usd
CY2022 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
32054326 usd
CY2021 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
51369216 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-32540422 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-128247751 usd
CY2022 migi Proceeds From Issuance Of Shares And Warrants
ProceedsFromIssuanceOfSharesAndWarrants
6698221 usd
CY2021 migi Proceeds From Issuance Of Shares And Warrants
ProceedsFromIssuanceOfSharesAndWarrants
85102014 usd
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
3600000 usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2021 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
20301427 usd
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
793172 usd
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
6122429 usd
CY2022 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
34256475 usd
CY2021 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
14269454 usd
CY2022 us-gaap Repayments Of Debt
RepaymentsOfDebt
1776144 usd
CY2021 us-gaap Repayments Of Debt
RepaymentsOfDebt
230962 usd
CY2022 migi Payments Of Borrowings
PaymentsOfBorrowings
27998884 usd
CY2021 migi Payments Of Borrowings
PaymentsOfBorrowings
3465044 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13986496 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
109854460 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-223376 usd
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-206039 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4521008 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4354462 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5467273 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1112811 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
946265 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5467273 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
5877091 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
653506 usd
CY2022 migi Sale Of Site In Exchange For Shares
SaleOfSiteInExchangeForShares
7048144 usd
CY2022 migi Sale Of Property And Equipment In Exchange For Shares
SaleOfPropertyAndEquipmentInExchangeForShares
3642113 usd
CY2022 us-gaap Change In Reporting Entity Other Comprehensive Income Loss After Tax
ChangeInReportingEntityOtherComprehensiveIncomeLossAfterTax
49080000.00 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
18870000 usd
CY2022Q4 us-gaap Assets Net
AssetsNet
81120000 usd
CY2022Q4 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
117310000 usd
CY2022Q4 us-gaap Cash Available For Distributions
CashAvailableForDistributions
950000 usd
CY2022Q3 migi Purchase And Sale Agreement Description
PurchaseAndSaleAgreementDescription
the Company entered into a (i) Purchase and Sale Agreement (“Purchase Agreement”) with CleanSpark, Inc. (“CleanSpark”), and (ii) an Equipment Purchase and Sale Agreement. Pursuant of the Purchase Agreement, CleanSpark assumed from the Company a lease for approximately 16.35 acres of real property located in Sandersville, Washington County, Georgia, and all personal property situated on the property. This transaction closed on October 8, 2022, and CleanSpark paid the following consideration to the Company pursuant to the Purchase Agreement: (i) $13.50 million in cash; (ii) 1,590,175 shares of common stock, par value $0.001 per share, of CleanSpark (valued at $4.8 million on October 7, 2022), and (iii) $6.5 million in seller financing in the form of promissory notes. Pursuant to the Equipment Purchase and Sale Agreement, CleanSpark’s subsidiary purchased from the Company, application-specific integrated circuit miners for $9.48 million in cash (which was later reduced to $9.02 million by amendment). This transaction initially closed on October 8, 2022, and was amended on October 21, 2022.
CY2022Q4 dei Entity Public Float
EntityPublicFloat
75000000 usd
CY2020Q4 migi Digital Currencies Balance
DigitalCurrenciesBalance
0.52
CY2022 migi Additions Of Digital Currencies1
AdditionsOfDigitalCurrencies1
1342.59
CY2021 migi Additions Of Digital Currencies1
AdditionsOfDigitalCurrencies1
808.88
CY2022 migi Sale Of Digital Currencies1
SaleOfDigitalCurrencies1
-1343.51
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"> <tr style="vertical-align: top"> <td style="width: 72px"> </td> <td style="width: 24px"><span style="font-size: 10pt">a.</span></td> <td><span style="font-size: 10pt">Use of estimates in preparation of Financial Statements:</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: -1cm"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify">The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and accompanying notes. The Company evaluates on an ongoing basis its assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: -1cm"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify">These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the consolidated financial statements, and the reported amounts of income and expenses during the reporting periods. Actual results could differ from those estimates. The Company has considered the following to be significant estimates made by management, including but not limited to, going concern assumptions, estimating the useful lives of fixed assets, realization of long-lived assets, unrealized tax positions and the realization of digital currencies, valuing the derivative asset classified under Level 3 fair value hierarchy, business combinations, reverse asset acquisition, and the contingent obligation with respect to future revenues.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: -1cm"> </p>
CY2022 migi Reverse Stock Split Description
ReverseStockSplitDescription
Pursuant to that certain Certificate of Amendment to the Certificate of Incorporation of the Company dated February 6, 2023, Mawson executed at a ratio of 1-6 reverse stock split of its outstanding common stock and reduced its authorized common stock to 90,000,000 shares, as set forth in the Company’s Current Report on Form 8-K filed February 9, 2023. 
CY2021 migi Sale Of Digital Currencies1
SaleOfDigitalCurrencies1
-808.48
CY2022Q4 migi Digital Currencies Balance
DigitalCurrenciesBalance
0
CY2021Q4 migi Digital Currencies Balance
DigitalCurrenciesBalance
0.92
CY2021Q4 migi Digital Currencies Balance
DigitalCurrenciesBalance
0.92
CY2022 migi Reverse Asset Acquisition Description
ReverseAssetAcquisitionDescription
Under the terms of the Cosmos Transaction Bid Implementation Agreement, the Company was required to make share-based payments consisting of up to 40,000,000 shares (pre 1-10 reverse stock split which occurred on August 11, 2021 and 1-6 reverse stock split which occurred February 6, 2023) under an Incentive Compensation Program and warrants issued to HC Wainwright as a fee related to the acquisition of common stock by Mawson of Mawson AU.
CY2022Q4 us-gaap Derivative Assets Noncurrent
DerivativeAssetsNoncurrent
11299971 usd
CY2022Q4 us-gaap Marketable Securities
MarketableSecurities
3243957 usd
CY2021Q4 us-gaap Marketable Securities
MarketableSecurities
326801 usd
CY2022 us-gaap Earnings Per Share Basic Distributed
EarningsPerShareBasicDistributed
4.16
CY2021 us-gaap Earnings Per Share Basic Distributed
EarningsPerShareBasicDistributed
4.79
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"> <tr style="vertical-align: top"> <td style="width: 72px; text-align: justify"> </td> <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">q.</span></td> <td style="text-align: justify"><span style="font-size: 10pt">Concentrations of credit risk:</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -1cm"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents and marketable securities. Cash and cash equivalents and restricted bank deposits are invested in banks in Australia and the U.S. If the counterparty completely failed to perform in accordance with the terms of the contract, the maximum amount of loss to the Company would be the balance. Management believes that the financial institutions that hold the Company’s investments are financially sound and, accordingly, minimal credit risk exists with respect to these investments. The Company has no off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify"> </p>
CY2022 us-gaap Increase Decrease In Other Regulatory Assets
IncreaseDecreaseInOtherRegulatoryAssets
3130638 usd
CY2022 migi Increasedecrease Depriciation Charge
IncreasedecreaseDepriciationCharge
84735 usd
CY2022 migi Treasury Bond Term
TreasuryBondTerm
P10Y
CY2022 migi Denominator
Denominator
-52762308 usd
CY2021 migi Denominator
Denominator
-44963720 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
shares
CY2022 migi Warrants To Purchase Common Stock
WarrantsToPurchaseCommonStock
2825278 shares
CY2021 migi Warrants To Purchase Common Stock
WarrantsToPurchaseCommonStock
626278 shares
CY2022 migi Options To Purchase Common Stock
OptionsToPurchaseCommonStock
4910 shares
CY2021 migi Options To Purchase Common Stock
OptionsToPurchaseCommonStock
125577 shares
CY2022 migi Restricted Stock Units Rs Us Issued Under A Management Equity Plan
RestrictedStockUnitsRSUsIssuedUnderAManagementEquityPlan
420914 shares
CY2021 migi Restricted Stock Units Rs Us Issued Under A Management Equity Plan
RestrictedStockUnitsRSUsIssuedUnderAManagementEquityPlan
377381 shares
CY2022 migi Total Of Diluted Loss Per Share
TotalOfDilutedLossPerShare
3251102 shares
CY2021 migi Total Of Diluted Loss Per Share
TotalOfDilutedLossPerShare
1139236 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12695654 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9383971 shares
CY2021Q3 us-gaap Excess Stock Shares Authorized
ExcessStockSharesAuthorized
120000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2022Q4 migi Intellectual Property And Equipment
IntellectualPropertyAndEquipment
4159452 usd
CY2022Q4 us-gaap Business Combination Contingent Consideration Asset
BusinessCombinationContingentConsiderationAsset
4159452 usd
CY2022 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
2060779 usd
CY2022Q4 migi Consideration Total
ConsiderationTotal
2098673 usd
CY2022Q4 us-gaap Other Restricted Assets Noncurrent
OtherRestrictedAssetsNoncurrent
170771 usd
CY2022Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
1453529 usd
CY2022Q4 migi Intellectual Property
IntellectualProperty
505417 usd
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
31044 usd
CY2022Q4 migi Purchase Price Allocation Total
PurchasePriceAllocationTotal
2098673 usd
CY2022Q4 migi Trade Receivables
TradeReceivables
10458076 usd
CY2021Q4 migi Trade Receivables
TradeReceivables
5606780 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
149796148 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
95150522 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
54489966 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18213672 usd
CY2022Q4 migi Reclassification To Assets Held For Sales
ReclassificationToAssetsHeldForSales
4289684 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
91016498 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
76936850 usd
CY2022 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
63200178 usd
CY2022 migi Depreciation Charge
DepreciationCharge
5290000 usd
CY2022 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
63200000 usd
CY2022 us-gaap Assets Disposed Of By Method Other Than Sale In Period Of Disposition Gain Loss On Disposition1
AssetsDisposedOfByMethodOtherThanSaleInPeriodOfDispositionGainLossOnDisposition1
3.74 usd
CY2022 us-gaap Gain Loss On Sale Of Interest In Projects
GainLossOnSaleOfInterestInProjects
4.16 usd
CY2022 us-gaap Depletion
Depletion
5.45 usd
CY2022 migi Writeoff Of Miners Amount
WriteoffOfMinersAmount
1560000 usd
CY2022 us-gaap Equipment Expense
EquipmentExpense
32050000.00 usd
CY2022 migi Refundable Security Deposits
RefundableSecurityDeposits
2524065 usd
CY2021 migi Refundable Security Deposits
RefundableSecurityDeposits
1246236 usd
CY2022Q4 us-gaap Property Plant And Equipment Owned Net
PropertyPlantAndEquipmentOwnedNet
4289684 usd
CY2022Q4 us-gaap Security Deposit
SecurityDeposit
1010716 usd
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
145659 usd
CY2022Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
5446059 usd
CY2022Q4 us-gaap Land Subject To Ground Leases
LandSubjectToGroundLeases
16.35 acre
CY2022Q3 us-gaap Area Of Land
AreaOfLand
1076 sqft
CY2022Q3 us-gaap Land Subject To Ground Leases
LandSubjectToGroundLeases
6 acre
CY2022Q1 us-gaap Lessor Operating Lease Option To Extend
LessorOperatingLeaseOptionToExtend
The term of the lease is for 5 years, with 2 options to extend for 5 years each.
CY2022Q2 us-gaap Land Subject To Ground Leases
LandSubjectToGroundLeases
11 acre
CY2022 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
28662 usd
CY2021 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
792 usd
CY2022 migi Interest On Lease Obligations1
InterestOnLeaseObligations1
8507 usd
CY2021 migi Interest On Lease Obligations1
InterestOnLeaseObligations1
317 usd
CY2022Q4 us-gaap Accounts Payable Trade Current And Noncurrent
AccountsPayableTradeCurrentAndNoncurrent
18152399 usd
CY2021Q4 us-gaap Accounts Payable Trade Current And Noncurrent
AccountsPayableTradeCurrentAndNoncurrent
4778784 usd
CY2022Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
2164178 usd
CY2021Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
1790921 usd
CY2022Q4 us-gaap Deferred Income
DeferredIncome
2000000 usd
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
1881897 usd
CY2021Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
754376 usd
CY2022Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
1702032 usd
CY2021Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
422907 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
25900506 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
7746988 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
28120477000000 usd
CY2022Q4 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
23610583000000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4509894000000 usd
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
28089975 usd
CY2022Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
30502 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
28120477 usd
CY2022Q4 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
7110000 usd
CY2022Q4 us-gaap Long Term Debt Percentage Bearing Fixed Interest Rate
LongTermDebtPercentageBearingFixedInterestRate
0.12 pure
CY2022 us-gaap Long Term Debt Average Amount Outstanding
LongTermDebtAverageAmountOutstanding
10210000 usd
CY2022Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
5700000 usd
CY2022 us-gaap Debt Instrument Description
DebtInstrumentDescription
Mawson Infrastructure Group Pty Ltd entered into a Secured Loan Facility Agreement with W Capital Advisors Pty Ltd with a total loan facility of AUD$3 million (USD$1.9 million). This was amended on September 29, 2022 and the loan facility was increased to AUD$8 million (USD$5.2 million). As at December 31, 2022, AUD$4.96 million (USD$3.37 million) has been drawn down from this facility, all of which is classified as a current liability.
CY2022Q4 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.12 pure
CY2022Q3 us-gaap Debt Instrument Periodic Payment Principal
DebtInstrumentPeriodicPaymentPrincipal
3600000 usd
CY2022Q4 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
3100000 usd
CY2022Q3 migi Significant Transactions Description
SignificantTransactionsDescription
the Company entered into a (i) Purchase and Sale Agreement with CleanSpark, and (ii) an Equipment Purchase and Sale Agreement. Pursuant of the Purchase Agreement, CleanSpark assumed from the Company a lease for approximately 16.35 acres of real property located in Sandersville, Washington County, Georgia, and all personal property situated on the Property. This transaction closed on October 8, 2022, and CleanSpark paid the following consideration to the Company pursuant to the Purchase Agreement: (i) $13.50 million in cash; (ii) 1,590,175 shares of common stock, par value $0.001 per share of CleanSpark (valued at $4.8 million on October 7, 2022), and (iii) $6.5 million in Seller financing in the form of promissory notes. Pursuant to the Equipment Purchase Agreement, CleanSpark purchased from the Company, application-specific integrated circuit miners, this transaction closed on October 8, 2022, for $9.48 million in cash (which was later reduced to $9.02 million upon reduction in the number of miners). There is also additional potential consideration payable pursuant to the Purchase and Sale Agreement of; (i) up to 1,100,890 shares of CleanSpark Common Stock dependent the number of modular data centers on the Property occupied by the Company being emptied and made available for use by CleanSpark. We achieved this additional consideration on December 30, 2022 and received the shares on January 13, 2023, and (ii) $2 million in cash if CleanSpark is able to utilize at least an additional 150 MW of power on the property by the six month anniversary of the Closing Date, this was not achieved by the end of December 31, 2022.
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
22517954 usd
CY2022Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
6500000 usd
CY2022Q4 us-gaap Common Stock Discount On Shares
CommonStockDiscountOnShares
4802329 usd
CY2022Q4 us-gaap Supplemental Deferred Purchase Price
SupplementalDeferredPurchasePrice
33820283 usd
CY2022Q4 migi Earnout Shares Of Clsk Common Stock
EarnoutSharesOfCLSKCommonStock
2245815 usd
CY2022Q4 us-gaap Asset Acquisition Contingent Consideration Liability
AssetAcquisitionContingentConsiderationLiability
2245815 usd
CY2022Q4 us-gaap Sale Of Stock Consideration Received Per Transaction
SaleOfStockConsiderationReceivedPerTransaction
36066098 usd
CY2022Q4 migi Processing Machines Miners Cost
ProcessingMachinesMinersCost
9051369 usd
CY2022Q4 migi Impairment On Miners
ImpairmentOnMiners
5447199 usd
CY2022Q4 migi Modular Data Center Cost
ModularDataCenterCost
7669285 usd
CY2022Q4 migi Transformers Cost
TransformersCost
2591275 usd
CY2022Q4 migi Plant And Equipment
PlantAndEquipment
2695144 usd
CY2022Q4 us-gaap Other General Expense
OtherGeneralExpense
335386 usd
CY2022Q4 migi Total Costs Associated With Sale Of Assets
TotalCostsAssociatedWithSaleOfAssets
27789658 usd
CY2022Q4 migi Profit On Sale Of Site
ProfitOnSaleOfSite
8276440 usd
CY2022Q4 migi Ownership Percentage
OwnershipPercentage
0.349 pure
CY2022 us-gaap Impairment Of Ongoing Project
ImpairmentOfOngoingProject
2.1 usd
CY2022Q3 us-gaap Loans Assumed1
LoansAssumed1
3000000 aud
CY2022Q3 us-gaap Loans Assumed1
LoansAssumed1
1900000 usd
CY2022Q3 us-gaap Line Of Credit Facility Increase Decrease Other Net
LineOfCreditFacilityIncreaseDecreaseOtherNet
8000000 aud
CY2022Q3 us-gaap Line Of Credit Facility Increase Decrease Other Net
LineOfCreditFacilityIncreaseDecreaseOtherNet
5200000 usd
CY2022 us-gaap Line Of Credit Facility Increase Decrease Other Net
LineOfCreditFacilityIncreaseDecreaseOtherNet
4960000 aud
CY2022 us-gaap Line Of Credit Facility Increase Decrease Other Net
LineOfCreditFacilityIncreaseDecreaseOtherNet
3370000 usd
CY2022Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.12 pure
CY2022 migi Mature Term
MatureTerm
March 2023
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-52300000 usd
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
-277717 usd
CY2021 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
-277717 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-10988857 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1069093 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0204 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-1435961 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.0274 pure
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
13703637 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.262 pure
CY2022 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-209726 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.004 pure
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
15762452 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
6244902 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
782080 usd
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
911463 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
166650 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
88833 usd
CY2022 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
2473377 usd
CY2021 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
714428 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
5874815 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
4710358 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
2548266 usd
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
425302 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
186432 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
32853 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
27794072 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
13128139 usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
770635 usd
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
934086 usd
CY2022 migi Depreciationsother
Depreciationsother
1112435 usd
CY2021 migi Depreciationsother
Depreciationsother
-13311 usd
CY2022Q4 migi Deferred Tax Liabilities Total
DeferredTaxLiabilitiesTotal
1883071 usd
CY2021Q4 migi Deferred Tax Liabilities Total
DeferredTaxLiabilitiesTotal
920775 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
25911002 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
12207364 usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
13700000 usd
CY2022 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
45600000 usd
CY2022 us-gaap Development Costs
DevelopmentCosts
300000 usd
CY2022 migi Purchasesandsaleagreementdescription
Purchasesandsaleagreementdescription
On February 7, 2023, the Company entered into a share purchase agreement with N. Danenberg Holding (2000) Ltd to sell the Company’s shares or interests in Wize NC Inc, Occuwize Ltd and Wize Pharma Ltd (“Wize Entities”) effective December 31, 2022 in consideration for $10,000.
CY2022Q2 us-gaap Shares Issued
SharesIssued
1666 shares
CY2022 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
408854 shares
CY2022 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
1310 shares
CY2022Q4 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
88168 shares
CY2022 migi Stock Split Description
StockSplitDescription
Pursuant to that certain Certificate of Amendment to the Certificate of Incorporation of the Company dated February 6, 2023 Mawson executed at a ratio of 1-6 reverse stock split of its outstanding common stock and reduced its authorized common stock to 90,000,000 shares, as set forth in the Company’s Current Report on Form 8-K filed February 9, 2023. 
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
587365 shares
CY2022 us-gaap Stock Issued During Period Shares Employee Stock Ownership Plan
StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan
2450580 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.17
CY2022 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P3Y6M14D
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
212667 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
2825278 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.17
CY2022 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P3Y6M14D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2825278 shares
CY2022Q1 us-gaap Warrants And Rights Outstanding Maturity Date
WarrantsAndRightsOutstandingMaturityDate
2023-08-23
CY2022Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
641667 shares
CY2022Q1 us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
6.5
CY2022Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
20000000 usd
CY2022Q3 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1333333 shares
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1666667 shares
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.01
CY2022Q3 migi Warrants To Purchase Shares
WarrantsToPurchaseShares
93333 shares
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
212667 shares
CY2022Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P5Y
CY2022Q1 migi Lease Extend Term
LeaseExtendTerm
P5Y
CY2022Q1 migi Rent Expenses Percentage
RentExpensesPercentage
0.04 pure
CY2022Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
240000 usd
CY2022 us-gaap Cost Maintenance
CostMaintenance
239977 usd
CY2021 us-gaap Cost Maintenance
CostMaintenance
81598 usd
CY2021Q4 migi Assets Held For Sales
AssetsHeldForSales
usd
CY2022Q4 migi Cryptocurrencies
Cryptocurrencies
usd
CY2021Q4 us-gaap Derivative Assets Noncurrent
DerivativeAssetsNoncurrent
usd
CY2022Q4 migi Equipment Deposits
EquipmentDeposits
usd
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
usd
CY2021Q4 us-gaap Other Loans Payable Long Term
OtherLoansPayableLongTerm
usd
CY2022 us-gaap Sublease Income
SubleaseIncome
usd
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
usd
CY2021 migi Loss On Reclassification To Assets Held For Sale
LossOnReclassificationToAssetsHeldForSale
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.61
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.80
CY2022 migi Lo2 A Write Offs
LO2AWriteOffs
usd
CY2021 migi Unrealized Loss On Marketable Securities
UnrealizedLossOnMarketableSecurities
usd
CY2021 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
usd
CY2021 us-gaap Other Noncash Income
OtherNoncashIncome
usd
CY2021 migi Impairment On Equity Accounted Associate Investment
ImpairmentOnEquityAccountedAssociateInvestment
usd
CY2021 migi Proceeds Received In The Form Of Shares
ProceedsReceivedInTheFormOfShares
usd
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
CY2021 migi Noncontrolling Interest
NoncontrollingInterest
usd
CY2022 migi Interest On Convertible Notes Satisfied By Issue Of Notes
InterestOnConvertibleNotesSatisfiedByIssueOfNotes
usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
usd
CY2022 migi Acquisition Of Wize Pharma Inc
AcquisitionOfWizePharmaInc
usd
CY2022 migi Gain Loss Noncontrolling Interest
GainLossNoncontrollingInterest
usd
CY2021 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
usd
CY2021 us-gaap Proceeds From Sale Of Other Assets Investing Activities
ProceedsFromSaleOfOtherAssetsInvestingActivities
usd
CY2022 migi Purchase Of Investment Shares
PurchaseOfInvestmentShares
usd
CY2022 migi Advances Made To External Companies
AdvancesMadeToExternalCompanies
usd
CY2021 migi Advances Made To External Companies
AdvancesMadeToExternalCompanies
usd
CY2021 migi Sale Of Site In Exchange For Shares
SaleOfSiteInExchangeForShares
usd
CY2021 migi Sale Of Property And Equipment In Exchange For Shares
SaleOfPropertyAndEquipmentInExchangeForShares
usd
CY2021Q4 us-gaap Derivative Assets Noncurrent
DerivativeAssetsNoncurrent
usd
CY2021Q4 migi Reclassification To Assets Held For Sales
ReclassificationToAssetsHeldForSales
usd
CY2021 migi Impairment Charges
ImpairmentCharges
usd
CY2021Q4 us-gaap Deferred Income
DeferredIncome
usd
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001218683

Files In Submission

Name View Source Status
migi-20221231_cal.xml Edgar Link unprocessable
0001213900-23-022430-index-headers.html Edgar Link pending
0001213900-23-022430-index.html Edgar Link pending
0001213900-23-022430.txt Edgar Link pending
0001213900-23-022430-xbrl.zip Edgar Link pending
f10k2022ex10-3_mawson.htm Edgar Link pending
f10k2022ex21-1_mawson.htm Edgar Link pending
f10k2022ex23-1_mawson.htm Edgar Link pending
f10k2022ex31-1_mawson.htm Edgar Link pending
f10k2022ex31-2_mawson.htm Edgar Link pending
f10k2022ex32-1_mawson.htm Edgar Link pending
f10k2022ex32-2_mawson.htm Edgar Link pending
f10k2022ex4-2_mawson.htm Edgar Link pending
f10k2022_mawsoninfra.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
migi-20221231.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
migi-20221231_def.xml Edgar Link unprocessable
migi-20221231_lab.xml Edgar Link unprocessable
migi-20221231_pre.xml Edgar Link unprocessable
f10k2022_mawsoninfra_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending